Additional Information
Book Details
Abstract
The goal of this book is to provide a conceptual framework for understanding the relationship between the ';psychological'; areas of medicine and the more somatic aspects of health care in our current social environment.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| CONTENTS | vii | ||
| ACKNOWLEDGEMENTS | vi | ||
| FOREWORD | xi | ||
| PREFACE | xv | ||
| PSYCHOSOMATIC MEDICINE: PAST AND PRESENT | 1 | ||
| HISTORICAL ANTECEDENTS | 2 | ||
| THE CONCEPT OF PSYCHOGENESIS | 3 | ||
| THE CONCEPT OF HOLISM | 10 | ||
| PSYCHOSOMATIC MEDICINE: THE FIRST PHASE | 15 | ||
| NEW TRENDS IN THEORY AND RESEARCH | 20 | ||
| THE CORE QUESTIONS | 24 | ||
| CORE THEORETICAL CONCEPTS | 26 | ||
| NEW TRENDS IN CLINICAL APPLICATION | 30 | ||
| THE KEY DEFINITIONS | 32 | ||
| CLASSIFICATION OF PSYCHOSOMATIC RESEARCH | 38 | ||
| PSYCHOPHYSIOLOGICAL STUDIES | 39 | ||
| PSYCHOENDOCRINOLOGY | 41 | ||
| PSYCHOIMMUNOLOGY | 42 | ||
| PSYCHONEUROPHYSIOLOGY | 44 | ||
| ETIOLOGIC STUDIES | 47 | ||
| SOMATOPSYCHIC STUDIES | 58 | ||
| THERAPY-RELATED STUDIES | 60 | ||
| CONCLUSIONS | 61 | ||
| REFERENCES | 63 | ||
| PSYCHIATRIC MANIFESTATIONS OF STRUCTURAL BRAIN DISEASE | 75 | ||
| POST-STROKE MOOD DISORDERS | 76 | ||
| CLINICAL MANIFESTATIONS | 77 | ||
| PREVALENCE AND DURATION OF DEPRESSIVE DISORDERS | 78 | ||
| PREVALENCE | 78 | ||
| DURATION | 79 | ||
| MECHANISMS OF POST-STROKE MOOD DISORDERS | 80 | ||
| BIOLOGICAL MARKERS OF POST-STROKE DEPRESSION | 82 | ||
| TREATMENT | 83 | ||
| ACKNOWLEDGEMENTS | 88 | ||
| MENTAL CHANGES IN MENINGOENCEPHALITIS AND CEREBRAL CYSTICERCOSIS | 89 | ||
| INTRODUCTION AND HISTORY | 89 | ||
| PSYCHIATRIC SYMPTOMS IN ACUTE VIRAL ENCEPHALITIS | 90 | ||
| PSYCHIATRIC MANIFESTATIONS IN TUBERCULOUS MENINGOENCEPHALITIS FUNGIMENINGITIS AND OTHER BACTERIAL INFECTIONS | 93 | ||
| PSYCHIATRIC DISORDERS IN CEREBRAL CYSTICERCOSIS | 94 | ||
| SUMMARY AND CONCLUSIONS | 97 | ||
| REFERENCES PART A | 100 | ||
| REFERENCES PART B | 103 | ||
| DEMENTIA | 107 | ||
| DEMENTIA | 108 | ||
| CLINICAL SYMPTOMATOLOGY OF DEMENTIA | 110 | ||
| EPIDEMIOLOGY OF THE DEMENTIAS | 111 | ||
| CLASSIFICATION OF DEMENTIAS | 111 | ||
| ETIOLOGIC CLASSIFICATION OF DEMENTIAS | 112 | ||
| PRIMARY CORTICAL AND PRIMARY SUBCORTICAL DEMENTIAS | 115 | ||
| DIAGNOSIS OF DEMENTIA | 116 | ||
| NEUROPHYSIOLOGIC TESTING | 121 | ||
| RADIOLOGICAL DIAGNOSIS | 123 | ||
| PSYCHOLOGICAL TESTS | 123 | ||
| ALZHEIMER'S DISEASE | 124 | ||
| CRITERIA FOR THE CLINICAL DIAGNOSIS OF ALZHEIMER'S DISEASE | 126 | ||
| ALZHEIMER'S DISEASE. GENETICS | 127 | ||
| PATHOLOGICAL FINDINGS | 128 | ||
| ALZHEIMER'S DISEASE, IT'S RELATIONSHIP WITH OTHER CONDITIONS | 134 | ||
| A. DOWN'S SYNDROME | 134 | ||
| B. INFECTIONS | 135 | ||
| P. SLEEP APNEA. | 136 | ||
| E. ALUMINUM | 138 | ||
| F. OTHER | 138 | ||
| PICK'S DISEASE | 138 | ||
| PARKINSON'S DISEASE | 139 | ||
| AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX OF GUAM. | 140 | ||
| PROGRESSIVE SUPRANUCLEAR PALSY | 141 | ||
| HUNTINGTON'S DISEASE | 141 | ||
| DEMENTIA AND VASCULAR DISORDERS | 141 | ||
| CREUTZFELD-JAKOB DISEASE | 143 | ||
| GERTSMANN-STRAUSSLER-SCHEINKER'S DISEASE | 145 | ||
| DIALYSIS DEMENTIA. | 146 | ||
| OTHER CAUSES OF DEMENTIA AND DELIRIUM. | 147 | ||
| PSEUDODEMENTIA | 149 | ||
| THE FAMILY AND THE PATIENT WITH DEMENTIA | 150 | ||
| Acknowledgments: | 152 | ||
| BIBLIOGRAPHY | 153 | ||
| UNFOUNDED PHYSICAL COMPLAINTS: CONCEPTUAL AND EPIDEMIOLOGICAL ASPECTS | 177 | ||
| UNFOUNDED PHYSICAL COMPLAINTS: CONCEPTUAL AND EPIDEMIOLOGTCAL ASPECTS | 178 | ||
| CONCEPTUAL ISSUES | 178 | ||
| SOMATIZATION AS PSYCHIATRIC PHENOMENON | 181 | ||
| SOMATIZATION\" VS. \"PSYCHOLOGIZATION | 181 | ||
| PSYCHOSOCIAL DETERMINANTS OF SOMATIZATION | 182 | ||
| SOMATIZATION IN DEVELOPED NATIONS | 183 | ||
| SOMATIZATION AS CHARACTER TRAIT | 183 | ||
| PSYCHOSOMATIC\" VS. \"SOMATIZATION | 184 | ||
| THE COMPLEXITY OF CHRONIC PAIN SYNDROMES - THE CASE OF LOWBACK PAIN | 184 | ||
| GOLD STANDARDS'' IN MEDICINE | 185 | ||
| SCREENING THE SOMATIZER | 186 | ||
| DEPRESSION. ANXIETY AND SOMATIZATION | 186 | ||
| SOMATIZERS IN MEDICAL SETTINGS | 187 | ||
| INSTRUMENTS TO SCREEN THE SOMATIZER | 187 | ||
| THE SOMATIZER AND DSM III | 188 | ||
| EPIDEMIOLOGICAL ASPECTS EPIDEMIOLOGY OF SOMATIZATION IN THE COMMUNITY | 188 | ||
| NEW (POST-DSM III) OPERATIONAL CONSTRUCTS OF SOMATIZATION | 189 | ||
| SOMATIZATION AND THE DIAGNOSTIC INTERVIEW SCHEDULE | 190 | ||
| DEVELOPING AN OPERATIONAL CONSTRUCT OF SOMATIZATION FROM THE DIS | 190 | ||
| SOMATIZATION IN THE COMMUNITY: THE ECA STUDY | 191 | ||
| LOS ANGELES ECA DATA ON SOMATIZATION | 192 | ||
| CONSCLUSIONS | 196 | ||
| REFERENCES | 198 | ||
| PATIENTS WHO AMPLIFY BODILY SENSATIONS | 203 | ||
| PATIENTS WHO AMPLIFY BODILY SENSATIONS | 204 | ||
| AMPLIFYING OR MINIMIZING A SYMPTOM | 205 | ||
| PSYCHOLOGICAL REASONS FOR AMPLIFYING SYMPTOMS | 207 | ||
| INFLUENCES OF THE MEDICAL CARE PROCESS ON AMPLIFICATION OF SYMPTOMS | 212 | ||
| SITUATIONAL SOCIAL AND CULTURAL REASONS FOR AMPLIFYING SYMPTOMS | 215 | ||
| EVALUATION OF SOMATIC SYMPTOMS | 217 | ||
| REFERENCES | 225 | ||
| PSYCHIATRIC MANIFESTATIONS OF COMPLEX PARTIAL SEIZURES | 233 | ||
| PSYCHIATRIC MANIFESTATIONS OF COMPLEX PARTIAL SEIZURES | 234 | ||
| INTRODUCTION | 234 | ||
| CLASSIFICATION OF SEIZURE DISORDERS | 234 | ||
| BRIEF HISTORY OF PARTIAL SEIZURES | 235 | ||
| THE LIMBIC SYSTEM AND THE NEUROLOGY OF EMOTIONS | 240 | ||
| GENERAL EPIDEMILOGOCIAL CONSTDRATIONS OF EPILEPSY\r | 243 | ||
| PREVALENCE | 244 | ||
| PHYSIOPATHQLOGY OF SEIZURES | 245 | ||
| PSYCHIATRIC PHENOMENOLOGY OF PARTIAL SEIZURES | 246 | ||
| CLINICAL PRESENTATION OF COMPLEX PARTIAL SEIZURES | 247 | ||
| MANAGEMENT OF CPS | 258 | ||
| PSYCHOPHARMACOLOGICAL MANAGEMENT | 259 | ||
| CARBAMAZEPINE | 260 | ||
| NEUROSURGICAL TREATMENT OF CPS | 265 | ||
| CONCLUSIONS | 266 | ||
| REFERENCES | 275 | ||
| AFFECTIVE DISORDERS: DIAGNOSTIC ASSESSMENT AND CLINICALCONSIDERATIONS | 283 | ||
| AFFECTIVE DISORDERS: DIAGNOSTIC ASSESSMENT AND CLINICALCONSIDERATIONS | 284 | ||
| PHENOMENOLOGY OF DEPRESSIVE DISORDERS | 284 | ||
| ETIOLOGICAL FACTORS IN AFFECTIVE DISORDERS | 287 | ||
| GENETIC FACTORS | 290 | ||
| RECENT FINDINGS | 291 | ||
| PSYCHOLOGICAL MODELS | 292 | ||
| COGNITIVE ASPECTS IN DIAGNOSIS AND TREATMENT | 294 | ||
| SOCIOLOGICAL MODELS | 295 | ||
| SOCIAL NETWORKS AND SOCIAL SUPPORT SYSTEMS | 298 | ||
| THE WORKUP OF A PATIENT WITH MAJOR AFFECTIVE DISORDER | 302 | ||
| CLINICAL SUBTYPES OF MAJOR AFFECTIVE DISORDERS | 311 | ||
| DIFFERENTIAL DIAGNOSIS OF MAJOR AFFECTIVE DISORDER | 319 | ||
| MAJOR DEPRESSION | 319 | ||
| DIFFERENTIAL DIAGNOSES IN MANIC DEPRESSIVE ILLNESS | 320 | ||
| DSYTHYMIC DISORDERS | 321 | ||
| DIAGNOSTIC CRITERIA | 321 | ||
| CYCLOTHYMIC DISORDER | 322 | ||
| DIAGNOSTIC CRITERIA | 322 | ||
| DEPRESSION AND PHYSICAL ILLNESS | 323 | ||
| DEPRESSION AS A FIRST SIGN OF PHYSICAL ILLNESS | 324 | ||
| DEPRESSION SECONDARY TO PHYSICAL ILLNESS | 324 | ||
| DEPRESSION AND DRUG THERAPY | 324 | ||
| DEPRESSION MASKED BY COMPLAINTS OF PHYSICAL ILLNESS | 325 | ||
| GRIEF AND BEREAVEMENT | 325 | ||
| SEASONAL DEPRESSIONS | 326 | ||
| CROSS-CULTURAL ASPECTS OF DEPRESSION | 326 | ||
| CONCLUSIONS | 338 | ||
| REFERENCES | 340 | ||
| PRACTICAL MANAGEMENT OF DEPRESSIVE AND MANIC EPISODES | 351 | ||
| PRACTICAL MANAGEMENT OF DEPRESSIVE AND MANIC EPISODES | 352 | ||
| EVALUATION AND SELECTION OF TREATMENT | 353 | ||
| Approach to the patient | 353 | ||
| Identification of the depressive syndrome | 355 | ||
| Elimination of other disorders | 356 | ||
| Other characteristics that influence drug choice | 357 | ||
| SELECTION OF TREATMENT | 358 | ||
| Types of antidepressant drugs | 359 | ||
| PRESENTATION OF DRUG TREATMENT TO THE PATIENT | 362 | ||
| Understanding the basis of drug treatment of depression | 363 | ||
| Mechanics of treatment | 363 | ||
| Short term expectations and monitoring | 364 | ||
| Long range planning | 365 | ||
| INITIAL TREATMENT: MANAGEMENT OF THE INDEX EPISODE | 365 | ||
| Rate and specificity of drug response | 365 | ||
| Monitoring drug response | 366 | ||
| ADVERSE EFFECTS AND PRECAUTIONS | 368 | ||
| Tricyclic drugs | 368 | ||
| Monoamine oxidase inhibitors | 370 | ||
| Lithium salts | 372 | ||
| Anticonvulsants | 376 | ||
| MANAGEMENT OF NONRESPONSE | 376 | ||
| Augmentation of antidepressant treatment | 377 | ||
| Changing drug treatment | 379 | ||
| MANIC EPISODES | 380 | ||
| Approach to the patient and evaluation | 380 | ||
| Selection of treatment | 381 | ||
| Management of the episode | 382 | ||
| Prophylactic treatment | 383 | ||
| LONG-TERM PLANNING | 384 | ||
| CONCLUSIONS | 385 | ||
| Remarks: | 387 | ||
| REFERENCES | 388 | ||
| PSYCHIATRIC ASPECTS OF GASTROINTESTINAL DISEASE | 401 | ||
| PSYCHIATRIC FACTORS IN ESOPHAGEAL DISEASE | 402 | ||
| REVIEW OF ESOPHAGEAL PHYSIOLOGY | 403 | ||
| ACMIASIA | 404 | ||
| DIFFUSE ESOPHAGEAL SPASM. | 406 | ||
| RUMINATION | 408 | ||
| PRIMARY PSYCHIATRIC DISORDER | 409 | ||
| PEPTIC ULCER DISEASE (PUD) | 411 | ||
| EPIDEMIOOLOGICAL ASPECTS | 411 | ||
| HISTORICAL DATA ON HIND-GOT INTERACTIONS | 413 | ||
| GENETIC FACTORS | 414 | ||
| PSYCHOLOGICAL CONFLICTS | 416 | ||
| SYCHOLOGICAL VARIABLES IN WOMEN | 417 | ||
| PSiCnOSOClAL STRESSORS | 418 | ||
| TREATMENT APPROACHES | 419 | ||
| A) SOHATIC APPROACHES | 419 | ||
| B) PSYCnoPIlARMACOLOGICAL APPROACHES | 421 | ||
| C) PSYCHOTHERAPEUTIC APPROACHES | 423 | ||
| IRRITABLE BOWEL SYNDROME | 425 | ||
| EPIDEMIOLOGY | 425 | ||
| REVIEW OF INTESTINAL PHYSIOLOGY | 427 | ||
| RESEARCH ON BRAIN-GOT INTERACTION | 428 | ||
| DIAGNOSTIC CRITERIA FOR IBS | 429 | ||
| SEARCH FOR ETIOLOGICAL FACTORS | 430 | ||
| CLINICAL PHENOMENOLOGY | 432 | ||
| PSYCHOLOGICAL CHARACTERISTICS | 433 | ||
| TREATMENT APPROACHES | 435 | ||
| CONCLUSIONS | 440 | ||
| SECONDARY | 443 | ||
| REFERENCES | 449 | ||
| PSYCHIATRIC FACTORS IN MITRAL VALVE PROLAPSE | 463 | ||
| PSYCHIATRIC FACTORS IN MITRAL VALVE PROLAPSE | 464 | ||
| INTRODUCTION | 464 | ||
| PREVALENCE AND DIAGNOSTIC CRITERIA | 464 | ||
| CLINICAL PRESENTATION | 465 | ||
| PATHOPHYSIOLOGY | 466 | ||
| PSYCHIATRIC ASPECTS OF MVP | 469 | ||
| TREATMENT | 470 | ||
| THE CORONARY PRONE PERSONALITY | 473 | ||
| DEFINITION OF THE PROBLEM | 473 | ||
| DEFINITION OF THE CORONARY PRONE PERSONALITY | 473 | ||
| TESTING FOR TYPE A | 474 | ||
| EMPIRICAL BASIS | 476 | ||
| PHYSIOLOGICAL BASIS | 476 | ||
| PSYCHOLOGICAL BASIS | 476 | ||
| SOCIOLOGICAL VARIABLES | 478 | ||
| MODIFICATION OF TYPE A BEHAVIOR | 479 | ||
| CONTROVERSIES | 480 | ||
| REFERENCES | 482 | ||
| PART I. PSYCHOLOGIC FACTORS IN MYOCARDIAL INFARCTIONPART II. PSYCHOLOGIC FACTORS IN SUDDEN CARDIAC DEATH | 489 | ||
| PSYCHOLOGIC FACTORS IN MYOCARDIAL INFARCTION | 490 | ||
| PSYCHOLOGICAL REACTIONS DURING HOSPITALIZATION | 490 | ||
| Denial | 493 | ||
| Depression | 494 | ||
| Delirium | 499 | ||
| PSYCHOLOGICAL REACTIONS AFTER DISCHARGE | 500 | ||
| Psychological Symptoms | 501 | ||
| Sexual Adjustment | 508 | ||
| Occupational Adjustment | 510 | ||
| Physical Activity/Sports | 512 | ||
| PSYCHOLOGIC FACTORS IN SUDDEN CARDIAC DEATH | 514 | ||
| ANIMAL STUDIES | 517 | ||
| HUMAN STUDIES | 520 | ||
| CONCLUSION | 523 | ||
| REFERENCES | 526 | ||
| BIOPSYCHOSOCIAL ASPECTS OF RHEUMATOID ARTHRITIS | 531 | ||
| BIOPSYCHOSOCIAL ASPECTS OF RHEUMATOID ARTHRITIS | 532 | ||
| MEDICAL ASPECTS OF RHEUMATOID ARTHRITISEPIDEMIOLOGY | 533 | ||
| ETIOLOGY AND PATHOGENESIS | 534 | ||
| CLINICAL MANIFESTATIONS | 536 | ||
| DIAGNOSIS | 537 | ||
| TREATMENT | 539 | ||
| PROGNOSIS | 543 | ||
| PSYCHOLOGICAL AND SOCIAL ASPECTS OF RHEUMATOID ARTHRITISINFLUENCE OF PERSONALITY AND STRESS | 545 | ||
| Methodological Problems in Previous Studies | 545 | ||
| Childhood Conflicts Recalled by Patients and Siblings | 545 | ||
| The Role of Stress | 548 | ||
| Conclusions | 551 | ||
| HEALTH AND PSYCHOSOCIAL STATUS | 552 | ||
| PSYCHOSOCIAL IMPAIRMENT AND PSYCHIATRIC COMPLICATIONS | 557 | ||
| The impact on Sexuality, Marriage, and the Family | 558 | ||
| The Impact on Work | 560 | ||
| Chronic Pain | 565 | ||
| Psychotherapy | 569 | ||
| CONCLUSIONS | 572 | ||
| REFERENCES | 577 | ||
| EATING DISORDERS:ANOREXIA NERVOSA, BULIMIA NERVOSA AND OBESITY | 587 | ||
| EATING DISORDERS:ANOREXIA NERVOSA, BULIMIA NERVOSA AND OBESITY | 588 | ||
| INTRODUCTION | 588 | ||
| ANCKEXIA NERTOSA | 590 | ||
| HISTCRY AND EPIIEMICLOGICAL DATA | 590 | ||
| PREMORBID PERSONALITY TRAITS AND OTHER FACTORS ASSOCIATED WITH THE ILLUNESS\r | 593 | ||
| PHENOMELOGY\r | 594 | ||
| Symptoms And Signs | 594 | ||
| ETIOLOGY AND PRECIPITATING FACTORS\r | 595 | ||
| COMPLICATIONS AND ASSOCIATED CONOCOMMITANT DISEASE PROCESS\r | 596 | ||
| DIFFERENTIAL DIAGNOSIS\r | 598 | ||
| PROGNOSIS | 599 | ||
| TREATMENT | 600 | ||
| THERAPIES\r | 600 | ||
| BULIMIA NERVOSA | 607 | ||
| HISTORY AND EPIDEMIOLOGICAL DATA\r | 607 | ||
| INCIDENCE\r | 609 | ||
| PHENOMOLOGY\r | 611 | ||
| Signs and Symptoms | 611 | ||
| ETIOLOGY AND FBBCIFITftriMG FACTORS | 611 | ||
| MEEICAL COMHJCATICNS AND CCNCOMMITANT DISEASE HOCESS | 613 | ||
| DIFFERENTIAL DIAGNOSIS\r | 614 | ||
| MANAGEMENT AND TREATMENT | 616 | ||
| Inpatlent Treatment | 616 | ||
| Outpatient Treatment | 616 | ||
| Psycho-Educational Techniques | 617 | ||
| Group Therapy | 618 | ||
| Family Therapy | 619 | ||
| Behavioral Therapy | 619 | ||
| Cognitive Behavioral Therapy | 620 | ||
| Pyschodynamic Therapy | 620 | ||
| Pharmocologlcal Treatment | 620 | ||
| OBESITY | 623 | ||
| DEMOGRAPHIC AND EPIDEMIOLOGICAL \rDATA | 623 | ||
| PREMORBID PERSONALITY TRAITS ASSOCIATED WITH OBESITY | 625 | ||
| PHENOMELOGY\r | 626 | ||
| Predetermlnants of obesity | 627 | ||
| COMPLICATIONS RESULTING FROM OBESITY AND ASSICIATED OR CONCOMITANT DISEASE PROCESSES\r | 630 | ||
| Psychological complications. | 632 | ||
| DIFFERENTIAL DIAGNOSIS\r | 633 | ||
| PROGNOSTIC ASSESSMENT\r | 634 | ||
| TREATMENT REGIMENS\r | 635 | ||
| Mild obesity | 635 | ||
| Pharmacology | 645 | ||
| Other forms of therapy-psychoanalysis | 646 | ||
| CONCLUSION | 646 | ||
| ANOREXIA NERVOSA REFERENCES | 649 | ||
| BULIMIA REFERENCES | 654 | ||
| OBESITY REEBSMCBS | 659 | ||
| ACKNOWLEDGMENTS | 663 | ||
| Volume 2 | I | ||
| Psychoneuroendocrinology | M | ||
| Hypothalamic-Pituitary-Thyroid Axis | N | ||
| Hypothalamic-Pituitary-Adrenal Axis | S | ||
| Hypothalamic-Pituitary-Gonadal Axis | V | ||
| Growth Hormone | X | ||
| Prolactin | Z | ||
| Conclusions | AA | ||
| References | DD | ||
| Psychosomatic Considerations of Infertility | OO | ||
| Emotional Impact of Infertility | PP | ||
| Psychological Considerations of Current Therapies for Infertility | TT | ||
| Hormonal: | UU | ||
| Artificial insemination: | UU | ||
| In vitro fertilization and embryo transfer (IVE-ET): | XX | ||
| Gamete intra-fallopian transfer (GIFT) | YY | ||
| Surrogate motherhood: | BBB | ||
| Phychological Aspects of Infertility and the Infertility Specialist: | BBB | ||
| Role of the Psychiatrist and Other Mental Health Professionals | GGG | ||
| Psychotherapy with infertility patients | JJJ | ||
| Ethics of Reproductive Intervention | KKK | ||
| Conclusion | LLL | ||
| References | MMM | ||
| Sexual Dysfunction: Psychosomatic Perspectives | QQQ | ||
| Sexual Response and Function | QQQ | ||
| Neurologic and Endocrinologic Aspects of Sex | UUU | ||
| Illness and Sexuality | ZZZ | ||
| Drugs and Sexuality | AAAA | ||
| Sexuality in Pregnancy and the Puerperium | DDDD | ||
| Sexuality and Aging | EEEE | ||
| Psychosocial Influences on Sexuality | GGGG | ||
| The Sexual Dysfunctions | IIII | ||
| Evaluation of Sexual Dysfunction: A Biopsychosocial Approach | IIII | ||
| The Sexual Dysfunctions Inhibited Sexual Desire | LLLL | ||
| Male Erection Disorder (51) | NNNN | ||
| Female Sexual Arousal Disorders | TTTT | ||
| Inhibited Female Orgasm (51) | UUUU | ||
| Inhibited Male Orgasm (51) | WWWW | ||
| Premature Ejaculation (51) | ZZZZ | ||
| Functional Dyspareunia (51) | AAAAA | ||
| Functional Vaginismus (51) | BBBBB | ||
| The Treatment of Sexual Dysfunction | CCCCC | ||
| The Treatment of the Major Psychosexual Dysfunctions Sexual Desire Disorders | FFFFF | ||
| Psychosexual Therapy for ISD (24, 40, 60, 62, 98) | GGGGG | ||
| Sexual Arousal Disorders | HHHHH | ||
| Psychosexual Therapy for Erectile Dysfunction (40, 48) | IIIII | ||
| Female Sexual Arousal Disorder | JJJJJ | ||
| Psychosexual Therapy for Inhibited Female Excitement (40, 48) | JJJJJ | ||
| Inhibited Female Orgasm | JJJJJ | ||
| The Psychosexual Therapy of Primary Inhibited Female Orgasm (6, 101) | KKKKK | ||
| Psychosexual Therapy of Situational Inhibited Female Orgasm (48) | KKKKK | ||
| Inhibited Male Orgasm | LLLLL | ||
| Psychosexual Therapy of Inhibited Male Orgasm (Ejaculatory Incompetence) | LLLLL | ||
| Premature Ejaculation | MMMMM | ||
| Psychosexual Therapy of Premature Ejaculation (40, 48) | NNNNN | ||
| Functional Dyspareunia | NNNNN | ||
| Functional Vaginismus | NNNNN | ||
| The Psychosexual Therapy of Vaginismus (58) | OOOOO | ||
| Outcome of the New Sex Therapy | PPPPP | ||
| Sex and Depression | TTTTT | ||
| Conclusions | VVVVV | ||
| References | XXXXX | ||
| Psychiatric Aspects of Obstetrics and Gynecology | KKKKKK | ||
| Introduction | KKKKKK | ||
| Postpartum Depression | KKKKKK | ||
| The Significance of Postpartum Depression | MMMMMM | ||
| The detection of postpartum depression | NNNNNN | ||
| Etiology | OOOOOO | ||
| The Three Kinds of Postpartum Depressions | RRRRRR | ||
| Postpartum blues definition | RRRRRR | ||
| Etiology | SSSSSS | ||
| Clinical characteristics | SSSSSS | ||
| Psychodynamics | TTTTTT | ||
| Treatment | TTTTTT | ||
| Major Depression | TTTTTT | ||
| Clinical characteristics | TTTTTT | ||
| Differential diagnosis | UUUUUU | ||
| Psychodynamics | VVVVVV | ||
| Risk Factors | VVVVVV | ||
| Treatment | WWWWWW | ||
| Postpartun Psychosis | XXXXXX | ||
| Classification | XXXXXX | ||
| Clinical characteristics | XXXXXX | ||
| Treatment | YYYYYY | ||
| Depression During Pregnancy | ZZZZZZ | ||
| A past history of depressio | BBBBBBB | ||
| Effect on children | BBBBBBB | ||
| Postpartum psychiatric hospitalization | BBBBBBB | ||
| Recurrence and outcome | CCCCCCC | ||
| Neonaticide | CCCCCCC | ||
| Prevention | DDDDDDD | ||
| Conclusion | EEEEEEE | ||
| Pseudocyesis | EEEEEEE | ||
| Definition | EEEEEEE | ||
| History | EEEEEEE | ||
| Incidence | FFFFFFF | ||
| Clinical course | FFFFFFF | ||
| Diagnosis | HHHHHHH | ||
| Etiology | IIIIIII | ||
| Psychological factors | IIIIIII | ||
| Psychiatric Diagnoses | KKKKKKK | ||
| Endocrine factors | KKKKKKK | ||
| Treatment | LLLLLLL | ||
| Conclusion | MMMMMMM | ||
| Vomiting During Pregnancy | MMMMMMM | ||
| Introduction | MMMMMMM | ||
| Vomiting due to nonpregnancy causes | NNNNNNN | ||
| Third trimester vomiting | OOOOOOO | ||
| Morning Sickness | OOOOOOO | ||
| Definition | OOOOOOO | ||
| Etiology | OOOOOOO | ||
| Clinical characteristics | RRRRRRR | ||
| Treatment | SSSSSSS | ||
| Hyperemesis Gravidarum | TTTTTTT | ||
| Introduction | TTTTTTT | ||
| Definition | TTTTTTT | ||
| Psychological factors | UUUUUUU | ||
| Psychiatric diagnoses | VVVVVVV | ||
| Biological factors | VVVVVVV | ||
| Treatment | WWWWWWW | ||
| Chronic Pelvic Pain | XXXXXXX | ||
| Background | XXXXXXX | ||
| Anatomy and Physiology of Gynecologic Pain | YYYYYYY | ||
| The Meaning of Pain - Psychodynamic Factors | ZZZZZZZ | ||
| Methodologic Problems in Studies | AAAAAAAA | ||
| Clinical characteristics | BBBBBBBB | ||
| Effect on the physician | DDDDDDDD | ||
| Etiology | DDDDDDDD | ||
| The relationship between chronic pelvic pain and psychopathology | DDDDDDDD | ||
| The psychosomatic hypothesis | EEEEEEEE | ||
| The somatopsychic hypothesis | EEEEEEEE | ||
| Physical Factors | FFFFFFFF | ||
| Pelvic patholocy on laparoscopy | GGGGGGGG | ||
| Psychological Factors | HHHHHHHH | ||
| Psychiatric diagnoses | JJJJJJJJ | ||
| Sexual abuse | KKKKKKKK | ||
| Evaluation | KKKKKKKK | ||
| Treatment | LLLLLLLL | ||
| Conclusion | OOOOOOOO | ||
| References | QQQQQQQQ | ||
| Psychological Distress in Oncology Patients | GGGGGGGGG | ||
| Assessment Issues | GGGGGGGGG | ||
| Prevalence of Psychological Distress | LLLLLLLLL | ||
| Variables Related to Adjustment | PPPPPPPPP | ||
| Psychological Distress: Site-Specific Data | VVVVVVVVV | ||
| Breast Cancer | WWWWWWWWW | ||
| Psychological distress | WWWWWWWWW | ||
| Postmastectomy adjustment | AAAAAAAAAA | ||
| Predictors of adjustment to breast cancer | CCCCCCCCCC | ||
| Effects of Cancer on Sexual Activity | EEEEEEEEEE | ||
| Cancer Survivors | FFFFFFFFFF | ||
| Conclusion | JJJJJJJJJJ | ||
| References | QQQQQQQQQQ | ||
| A Model for Psychotherapy with the Early-State Cancer Patient | WWWWWWWWWW | ||
| Abstract | WWWWWWWWWW | ||
| Introduction | WWWWWWWWWW | ||
| An Integrated Model of Psychotherapy | YYYYYYYYYY | ||
| Psychodynamic Psychotherapeutic Issues in Cancer Patients | FFFFFFFFFFF | ||
| Fear Induced by the Disease Itself Include: | GGGGGGGGGGG | ||
| Fears Related to the Cancer Therapy Focus on: | GGGGGGGGGGG | ||
| Fears Related to Living with Cancer Include: | HHHHHHHHHHH | ||
| Specific Countertransference Issues | KKKKKKKKKKK | ||
| Additional Psychotherapeutic Issues | NNNNNNNNNNN | ||
| Developing a realistic attitude toward noncancer-related physical ailments. | NNNNNNNNNNN | ||
| Loss of a sense of omnipotence. | NNNNNNNNNNN | ||
| Assertion and competence. | OOOOOOOOOOO | ||
| Transference. | PPPPPPPPPPP | ||
| Fears of abandonment, rejection and isolation. | PPPPPPPPPPP | ||
| Conclusions | QQQQQQQQQQQ | ||
| References | SSSSSSSSSSS | ||
| Neuropsychiatric Complications of Cancer and Its Treatment | XXXXXXXXXXX | ||
| I. Objectives | YYYYYYYYYYY | ||
| II. Diagnostic Criteria | ZZZZZZZZZZZ | ||
| III. A Neuropsychiatric Approach in Examining Cancer Patients | ZZZZZZZZZZZ | ||
| IV. Organic Mental Disorders in Oncology | BBBBBBBBBBBB | ||
| A. Delirium | BBBBBBBBBBBB | ||
| B. Dementia | CCCCCCCCCCCC | ||
| C. Organic personality syndrome (OPS) | DDDDDDDDDDDD | ||
| D. Organic affective syndromes (OAS) | EEEEEEEEEEEE | ||
| E. Other organic disorders | EEEEEEEEEEEE | ||
| V. Depression and Cancer | FFFFFFFFFFFF | ||
| VI. Anxiety Disorders | IIIIIIIIIIII | ||
| VII. Pain | KKKKKKKKKKKK | ||
| VIII. Neurotoxicities | NNNNNNNNNNNN | ||
| IX. Nausea and Vomiting | TTTTTTTTTTTT | ||
| X. Quality of Life | WWWWWWWWWWWW | ||
| Summary | YYYYYYYYYYYY | ||
| References | NNNNNNNNNNNNN | ||
| Benzodiazepines | AAAAAAAAAAAAAA | ||
| Pharmacokinetic Properties | AAAAAAAAAAAAAA | ||
| Considerations in the Elderly | BBBBBBBBBBBBBB | ||
| Considerations in the Medically Ill | DDDDDDDDDDDDDD | ||
| Considerations in Pregnancy | GGGGGGGGGGGGGG | ||
| Benzodiazepine-Drug Interactions | IIIIIIIIIIIIII | ||
| Guidelines for Treatment of Anxiety Disorders Introduction | MMMMMMMMMMMMMM | ||
| Clinical Considerations in Initiating and Maintaining Treatment | OOOOOOOOOOOOOO | ||
| Guidelines for Withdrawal of a Benzodiazepine | TTTTTTTTTTTTTT | ||
| Alcohol Detoxification | VVVVVVVVVVVVVV | ||
| Treatment of Insomnia | YYYYYYYYYYYYYY | ||
| Benzodiazepines as Antidepressants | AAAAAAAAAAAAAAA | ||
| Benzodiazepines in the Treatment of Psychoses, Mania, and Agitated States Benzodiazepines in Psychoses | EEEEEEEEEEEEEEE | ||
| Benzodiazepines in Mania | HHHHHHHHHHHHHHH | ||
| Benzodiazepines in Delirious States | JJJJJJJJJJJJJJJ | ||
| Benzodiazepines in Acutely Agitated States | LLLLLLLLLLLLLLL | ||
| Conclusion | OOOOOOOOOOOOOOO | ||
| References | UUUUUUUUUUUUUUU | ||
| Psychological Aspects of Organ Transplantation | CCCCCCCCCCCCCCCC | ||
| Types of Transplant | DDDDDDDDDDDDDDDD | ||
| The Role of the Psychosocial Team | EEEEEEEEEEEEEEEE | ||
| Stages of Transplantation | GGGGGGGGGGGGGGGG | ||
| State I. Transplant Proposal | HHHHHHHHHHHHHHHH | ||
| Medical Factors in the Transplant Proposal Stage | IIIIIIIIIIIIIIII | ||
| Medical causes. | IIIIIIIIIIIIIIII | ||
| Cost of the transplant. | KKKKKKKKKKKKKKKK | ||
| Psychosocial Factors in the Transplant Proposal Stage | KKKKKKKKKKKKKKKK | ||
| Initial psychological reactions. | KKKKKKKKKKKKKKKK | ||
| Informed consent. | LLLLLLLLLLLLLLLL | ||
| Intervention Issues in the Transplant Proposal Stage | NNNNNNNNNNNNNNNN | ||
| Stage II. Evaluation | OOOOOOOOOOOOOOOO | ||
| Medical Factors in the Evaluation Stage | OOOOOOOOOOOOOOOO | ||
| Psychosocial Factors in the Evaluation Stage | PPPPPPPPPPPPPPPP | ||
| Need for selection. | PPPPPPPPPPPPPPPP | ||
| Psychiatric disorder as a contraindication. | SSSSSSSSSSSSSSSS | ||
| Social problems as a contraindication. | UUUUUUUUUUUUUUUU | ||
| Cognitive problems as a contraindication. | UUUUUUUUUUUUUUUU | ||
| Compliance, problems as a contraindication. | UUUUUUUUUUUUUUUU | ||
| Intervention Issues in the Evaluation Stage | VVVVVVVVVVVVVVVV | ||
| Predicting medical outcome. | VVVVVVVVVVVVVVVV | ||
| Predicting compliance. | XXXXXXXXXXXXXXXX | ||
| Predicting quality of life. | YYYYYYYYYYYYYYYY | ||
| Living related donors. | ZZZZZZZZZZZZZZZZ | ||
| The patient's decision. | AAAAAAAAAAAAAAAAA | ||
| Summary. | BBBBBBBBBBBBBBBBB | ||
| Stage III. Waiting for Donor Organ | CCCCCCCCCCCCCCCCC | ||
| Medical Factors in the Waiting Stage | CCCCCCCCCCCCCCCCC | ||
| Psychosocial Factors in the Waiting Stage | DDDDDDDDDDDDDDDDD | ||
| Intervention Issues in the Waiting Stage | FFFFFFFFFFFFFFFFF | ||
| Assisting patients. | FFFFFFFFFFFFFFFFF | ||
| Staff reactions. | HHHHHHHHHHHHHHHHH | ||
| Stage IV. perioperative Stage | IIIIIIIIIIIIIIIII | ||
| Medical Factors in the Perioperative Stage | IIIIIIIIIIIIIIIII | ||
| Psychosocial Factors in the Perioperative Stage | KKKKKKKKKKKKKKKKK | ||
| Intervention Issues in the Perioperative Stage | LLLLLLLLLLLLLLLLL | ||
| Stage V. Recovery | LLLLLLLLLLLLLLLLL | ||
| Medical Factors in the Recovery Stage | LLLLLLLLLLLLLLLLL | ||
| Psychosocial Factors in the Recovery Stage | NNNNNNNNNNNNNNNNN | ||
| Fear of graft rejection. | NNNNNNNNNNNNNNNNN | ||
| Immunosuppressant medications. | QQQQQQQQQQQQQQQQQ | ||
| Denial. | RRRRRRRRRRRRRRRRR | ||
| Family Concerns. | RRRRRRRRRRRRRRRRR | ||
| Intervention Issues in the Recovery Stage | RRRRRRRRRRRRRRRRR | ||
| Psychopharmacology. | RRRRRRRRRRRRRRRRR | ||
| Psychotherapy. | SSSSSSSSSSSSSSSSS | ||
| Brief counseling. | TTTTTTTTTTTTTTTTT | ||
| Traditional psychotherapy. | UUUUUUUUUUUUUUUUU | ||
| Group psychotherapy. | VVVVVVVVVVVVVVVVV | ||
| Consultation functions. | XXXXXXXXXXXXXXXXX | ||
| Stage VI. Post Discharge | YYYYYYYYYYYYYYYYY | ||
| Medical Factors in the Post Discharge Stage | YYYYYYYYYYYYYYYYY | ||
| Medical complications. | ZZZZZZZZZZZZZZZZZ | ||
| Noncompliance. | ZZZZZZZZZZZZZZZZZ | ||
| Psychosocial Factors in the Post Discharge Stage | AAAAAAAAAAAAAAAAAA | ||
| Post-transplant psychiatric disorder. | BBBBBBBBBBBBBBBBBB | ||
| Quality of life. | EEEEEEEEEEEEEEEEEE | ||
| Subjective quality of life. | EEEEEEEEEEEEEEEEEE | ||
| Objective quality of life. | FFFFFFFFFFFFFFFFFF | ||
| Sexual functioning. | HHHHHHHHHHHHHHHHHH | ||
| Family issues. | IIIIIIIIIIIIIIIIII | ||
| Intervention Issues in the Post Discharge Stage | IIIIIIIIIIIIIIIIII | ||
| Psychopathology. | IIIIIIIIIIIIIIIIII | ||
| Compliance. | JJJJJJJJJJJJJJJJJJ | ||
| Rehabilitation. | JJJJJJJJJJJJJJJJJJ | ||
| Sexual dysfunction. | LLLLLLLLLLLLLLLLLL | ||
| Conclusions | MMMMMMMMMMMMMMMMMM | ||
| References | OOOOOOOOOOOOOOOOOO | ||
| Organic and Psychiatric Aspects of Headache | CCCCCCCCCCCCCCCCCCC | ||
| Clinical Examination | GGGGGGGGGGGGGGGGGGG | ||
| Differential Diagnosis of Headaches | GGGGGGGGGGGGGGGGGGG | ||
| Tests to be Done in the Study of Headache (Modified from 5, 6, 7) | JJJJJJJJJJJJJJJJJJJ | ||
| Mechanism of Headache | KKKKKKKKKKKKKKKKKKK | ||
| Classification of Headaches | LLLLLLLLLLLLLLLLLLL | ||
| A. Muscle contraction headache: | LLLLLLLLLLLLLLLLLLL | ||
| B. Vascular headaches: | LLLLLLLLLLLLLLLLLLL | ||
| C. Diseases of the eye, ear, nose, tongue, throat and teeth. | LLLLLLLLLLLLLLLLLLL | ||
| D. Retention of CO2: | LLLLLLLLLLLLLLLLLLL | ||
| E. Neuralgias: | LLLLLLLLLLLLLLLLLLL | ||
| F. Atypical facial pain | LLLLLLLLLLLLLLLLLLL | ||
| G. Exertional headache. | LLLLLLLLLLLLLLLLLLL | ||
| H. Temperature and climate dependent headache: | LLLLLLLLLLLLLLLLLLL | ||
| I. Multiple sclerosis | LLLLLLLLLLLLLLLLLLL | ||
| J. Other types of headaches | LLLLLLLLLLLLLLLLLLL | ||
| Head Trauma and Headache | MMMMMMMMMMMMMMMMMMM | ||
| Muscle Contraction Headache | MMMMMMMMMMMMMMMMMMM | ||
| Treatment of the Contraction Headache | OOOOOOOOOOOOOOOOOOO | ||
| Psychogenic Headache | PPPPPPPPPPPPPPPPPPP | ||
| Vascular Headaches | RRRRRRRRRRRRRRRRRRR | ||
| Migraine Equivalent | VVVVVVVVVVVVVVVVVVV | ||
| Paramenstrual Migraine | VVVVVVVVVVVVVVVVVVV | ||
| Chronic Paroxysmal Hemicrania | VVVVVVVVVVVVVVVVVVV | ||
| Basilar Migraine | VVVVVVVVVVVVVVVVVVV | ||
| Cyclical Migraine | WWWWWWWWWWWWWWWWWWW | ||
| Opthalmoplegic Migraine | WWWWWWWWWWWWWWWWWWW | ||
| Hemiplegic Migraine | WWWWWWWWWWWWWWWWWWW | ||
| Treatment of Migraine | WWWWWWWWWWWWWWWWWWW | ||
| Prophylaxis of Migraine | XXXXXXXXXXXXXXXXXXX | ||
| Hypertension and Headaches | ZZZZZZZZZZZZZZZZZZZ | ||
| Pheochromocytoma | ZZZZZZZZZZZZZZZZZZZ | ||
| Cluster Headaches | ZZZZZZZZZZZZZZZZZZZ | ||
| Prophylactic Treatment of Cluster Headaches | AAAAAAAAAAAAAAAAAAAA | ||
| Temporal Arteritis | BBBBBBBBBBBBBBBBBBBB | ||
| Neuralgias and other Associated Pain Disorders | CCCCCCCCCCCCCCCCCCCC | ||
| Trigeminal Neuralgia | CCCCCCCCCCCCCCCCCCCC | ||
| Paratrigeminal Neuralgia (Raeder's neuralgia) | CCCCCCCCCCCCCCCCCCCC | ||
| Glossopharyngeal Neuralgia | DDDDDDDDDDDDDDDDDDDD | ||
| Superior Laryngeal Neuralgia | DDDDDDDDDDDDDDDDDDDD | ||
| Greater Occipital Neuralgia | DDDDDDDDDDDDDDDDDDDD | ||
| Ocular Origin of Headaches | DDDDDDDDDDDDDDDDDDDD | ||
| Ent Causes of Headache | EEEEEEEEEEEEEEEEEEEE | ||
| Sphenopalatine Neuralgia (Sluder's Neuralgia) | EEEEEEEEEEEEEEEEEEEE | ||
| Headache or Oral Origin | EEEEEEEEEEEEEEEEEEEE | ||
| Temporomandibular Joint Dysfunction | FFFFFFFFFFFFFFFFFFFF | ||
| Brain Tumors and Headache | FFFFFFFFFFFFFFFFFFFF | ||
| Pseudotumor Cerebri | FFFFFFFFFFFFFFFFFFFF | ||
| Sleep Apnea Headaches | GGGGGGGGGGGGGGGGGGGG | ||
| Atypical Facial Pain and Headache | GGGGGGGGGGGGGGGGGGGG | ||
| Headaches and Convulsive Disorder | HHHHHHHHHHHHHHHHHHHH | ||
| Exertional and Coital Cephalalgia | IIIIIIIIIIIIIIIIIIII | ||
| Sympathetic Neurovascular Reflex Dysfunction | IIIIIIIIIIIIIIIIIIII | ||
| Meningeal Irritation and Headaches | JJJJJJJJJJJJJJJJJJJJ | ||
| Multiple Sclerosis | KKKKKKKKKKKKKKKKKKKK | ||
| Post Lumbar Puncture Headache | KKKKKKKKKKKKKKKKKKKK | ||
| Uncommon Causes of Headaches | KKKKKKKKKKKKKKKKKKKK | ||
| Thermography and Headache | KKKKKKKKKKKKKKKKKKKK | ||
| Medication Overuse | LLLLLLLLLLLLLLLLLLLL | ||
| Biofeedback, Tens and Physical Therapy | LLLLLLLLLLLLLLLLLLLL | ||
| Conclusion: | MMMMMMMMMMMMMMMMMMMM | ||
| Acknowledgments: | MMMMMMMMMMMMMMMMMMMM | ||
| Bibliogaraphy | PPPPPPPPPPPPPPPPPPPP | ||
| Psychosomatic Illness and the Geriatric Patient | DDDDDDDDDDDDDDDDDDDDD | ||
| Introduction | DDDDDDDDDDDDDDDDDDDDD | ||
| Factors Influencine Symptom Presentation | DDDDDDDDDDDDDDDDDDDDD | ||
| Sociocultural factors | DDDDDDDDDDDDDDDDDDDDD | ||
| Psychodynamic factors | EEEEEEEEEEEEEEEEEEEEE | ||
| Cognitive Status | EEEEEEEEEEEEEEEEEEEEE | ||
| Case Vignette | FFFFFFFFFFFFFFFFFFFFF | ||
| Physical illness | GGGGGGGGGGGGGGGGGGGGG | ||
| Physical signs and symptoms of disease | GGGGGGGGGGGGGGGGGGGGG | ||
| Sleep | HHHHHHHHHHHHHHHHHHHHH | ||
| Sexuality | JJJJJJJJJJJJJJJJJJJJJ | ||
| Gastrointestinal Complaints | LLLLLLLLLLLLLLLLLLLLL | ||
| Ambiguous Presentations of Psychiatric Illness | MMMMMMMMMMMMMMMMMMMMM | ||
| Other Atypical Depressions | PPPPPPPPPPPPPPPPPPPPP | ||
| Hypochondriasis | QQQQQQQQQQQQQQQQQQQQQ | ||
| Adjustment reactions | TTTTTTTTTTTTTTTTTTTTT | ||
| Chronic pain | TTTTTTTTTTTTTTTTTTTTT | ||
| Psychosomatic disorders | WWWWWWWWWWWWWWWWWWWWW | ||
| Conclusion | XXXXXXXXXXXXXXXXXXXXX | ||
| References | AAAAAAAAAAAAAAAAAAAAAA | ||
| Disorders of Sphincter Control in Children | FFFFFFFFFFFFFFFFFFFFFF | ||
| Definition | GGGGGGGGGGGGGGGGGGGGGG | ||
| Etiology: Organic | KKKKKKKKKKKKKKKKKKKKKK | ||
| Etiology-Psychogenic | MMMMMMMMMMMMMMMMMMMMMM | ||
| Psychoanalytic | MMMMMMMMMMMMMMMMMMMMMM | ||
| Etiology: Behavioral | OOOOOOOOOOOOOOOOOOOOOO | ||
| Organic | QQQQQQQQQQQQQQQQQQQQQQ | ||
| Pediatric | RRRRRRRRRRRRRRRRRRRRRR | ||
| Psychoanalytic | UUUUUUUUUUUUUUUUUUUUUU | ||
| Behavioral | WWWWWWWWWWWWWWWWWWWWWW | ||
| Discussion | YYYYYYYYYYYYYYYYYYYYYY | ||
| Conclusions | CCCCCCCCCCCCCCCCCCCCCCC | ||
| Definition | EEEEEEEEEEEEEEEEEEEEEEE | ||
| Epidemiology | GGGGGGGGGGGGGGGGGGGGGGG | ||
| Etiology | IIIIIIIIIIIIIIIIIIIIIII | ||
| Treatment | PPPPPPPPPPPPPPPPPPPPPPP | ||
| Summary | ZZZZZZZZZZZZZZZZZZZZZZZ | ||
| References | EEEEEEEEEEEEEEEEEEEEEEEE | ||
| Evaluating Treatments in Medical Psychiatry | TTTTTTTTTTTTTTTTTTTTTTTT | ||
| Introduction | VVVVVVVVVVVVVVVVVVVVVVVV | ||
| Controls | VVVVVVVVVVVVVVVVVVVVVVVV | ||
| Randomization | YYYYYYYYYYYYYYYYYYYYYYYY | ||
| Type I and Type II Errors | ZZZZZZZZZZZZZZZZZZZZZZZZ | ||
| Sample Size | AAAAAAAAAAAAAAAAAAAAAAAAA | ||
| Measurement | BBBBBBBBBBBBBBBBBBBBBBBBB | ||
| Clinical Significance | DDDDDDDDDDDDDDDDDDDDDDDDD | ||
| Crossover Design | EEEEEEEEEEEEEEEEEEEEEEEEE | ||
| Parallel Design | GGGGGGGGGGGGGGGGGGGGGGGGG | ||
| Conclusions | HHHHHHHHHHHHHHHHHHHHHHHHH | ||
| References | MMMMMMMMMMMMMMMMMMMMMMMMM | ||
| Acknowledgments | QQQQQQQQQQQQQQQQQQQQQQQQQ | ||
| List of Contributors | RRRRRRRRRRRRRRRRRRRRRRRRR | ||
| Index | XXXXXXXXXXXXXXXXXXXXXXXXX |